BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23707252)

  • 21. Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network.
    Chung TW; Lin SY; Liu DZ; Tyan YC; Yang JS
    Int J Pharm; 2009 Dec; 382(1-2):39-44. PubMed ID: 19666095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injectable thermally responsive mucoadhesive gel for sustained protein delivery.
    Mayol L; Biondi M; Quaglia F; Fusco S; Borzacchiello A; Ambrosio L; La Rotonda MI
    Biomacromolecules; 2011 Jan; 12(1):28-33. PubMed ID: 21142090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of thermosensitive poloxamer 407-based microbubble gel with ultrasound mediation for inner ear drug delivery.
    Liao AH; Shih CP; Li MW; Lin YC; Chuang HC; Wang CH
    Drug Deliv; 2021 Dec; 28(1):1256-1271. PubMed ID: 34142922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphiphilic NLC-Gel formulation loaded with Sebacoyl dinalbuphine ester and Nalbuphine for localized postoperative pain management.
    Lin CL; Li YL; Chen YW; Kuo CH; Tu TY; Liu YF; Tsai JC; Shyong YJ
    Int J Pharm; 2024 Jun; 659():124295. PubMed ID: 38823469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats.
    Zhang K; Shi X; Lin X; Yao C; Shen L; Feng Y
    Drug Deliv; 2015 May; 22(3):375-82. PubMed ID: 24601854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and characterization of bioadhesive systems containing propolis or sildenafil for dental pulp protection.
    Fabri FV; Cupertino RR; Hidalgo MM; de Oliveira RM; Bruschi ML
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1446-54. PubMed ID: 21631394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo evaluation of a new sustained-release formulation of morphine.
    Araico A; Saadeddin A; Torres-Molina F; Peris JE
    Pharmazie; 2009 Oct; 64(10):653-5. PubMed ID: 19947167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro drug release and percutaneous behavior of poloxamer-based hydrogel formulation containing traditional Chinese medicine.
    Wang W; Hui PCL; Wat E; Ng FSF; Kan CW; Wang X; Wong ECW; Hu H; Chan B; Lau CBS; Leung PC
    Colloids Surf B Biointerfaces; 2016 Dec; 148():526-532. PubMed ID: 27690241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained-release of urease from a poloxamer gel matrix.
    Fults KA; Johnston TP
    J Parenter Sci Technol; 1990; 44(2):58-65. PubMed ID: 2338605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temperature-responsive and biodegradable PVA:PVP k30:poloxamer 407 hydrogel for controlled delivery of human growth hormone (hGH).
    Taheri A; Atyabi F; Dinarvnd R
    J Pediatr Endocrinol Metab; 2011; 24(3-4):175-9. PubMed ID: 21648286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poloxamer 407 based-nanoparticles for controlled release of methotrexate.
    Moura S; Noro J; Cerqueira P; Silva C; Cavaco-Paulo A; Loureiro A
    Int J Pharm; 2020 Feb; 575():118924. PubMed ID: 31870962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diffusion behaviors of drugs in thermosensitive in situ gels].
    Wei G; Lu WY; Zheng JM
    Yao Xue Xue Bao; 2004 Mar; 39(3):232-5. PubMed ID: 15171663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of thermosensitive poloxamer 407 gel systems for the sustained release of estradiol in a fish model.
    Cespi M; Bonacucina G; Pucciarelli S; Cocci P; Perinelli DR; Casettari L; Illum L; Palmieri GF; Palermo FA; Mosconi G
    Eur J Pharm Biopharm; 2014 Nov; 88(3):954-61. PubMed ID: 25194925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ethanol on the release of morphine sulfate from Oramorph SR tablets.
    Barkin RL; Shirazi D; Kinzler E
    Am J Ther; 2009; 16(6):482-6. PubMed ID: 19770796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled release ibuprofen-poloxamer gel for epidural use - A pharmacokinetic study using microdialysis in pigs.
    Paavola A; Bernards CM; Rosenberg PH
    Eur J Pharm Biopharm; 2016 Nov; 108():180-186. PubMed ID: 27615997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
    Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral suspensions of morphine hydrochloride for controlled release: rheological properties and drug release.
    Morales ME; López G; Gallardo V; Ruiz MA
    Mol Pharm; 2011 Apr; 8(2):629-34. PubMed ID: 21271730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermosensitive Gel-Based Formulation for Intratumoral Delivery of Toll-Like Receptor 7/8 Dual Agonist, MEDI9197.
    Fakhari A; Nugent S; Elvecrog J; Vasilakos J; Corcoran M; Tilahun A; Siebenaler K; Sun J; Subramony JA; Schwarz A
    J Pharm Sci; 2017 Aug; 106(8):2037-2045. PubMed ID: 28456734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poloxamer-Based Thermoreversible Gel for Topical Delivery of Emodin: Influence of P407 and P188 on Solubility of Emodin and Its Application in Cellular Activity Screening.
    Ban E; Park M; Jeong S; Kwon T; Kim EH; Jung K; Kim A
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28178225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.